• 1
    Walport MJ. Complement. Part 1. N Engl J Med 2001; 344: 105866.
  • 2
    Walport MJ. Complement. Part 2. N Engl J Med 2001; 344: 11404.
  • 3
    Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996; 271: 34850.
  • 4
    Walport MJ, Davies KA, Morley BJ, Botto M. Complement deficiency and autoimmunity. Ann NY Acad Sci 1997; 815: 26781.
  • 5
    Trouw LA, Roos A, Daha MR. Autoantibodies to complement components. Mol Immunol 2001; 38: 199206.
  • 6
    Siegert CE, Daha MR, Van Halma C, D V, Breedveld FC. IgG and IgA autoantibodies to C1q in systemic and renal diseases. Clin Exp Rheumatol 1992; 10: 1923.
  • 7
    Wisnieski JJ, Jones SM. IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases. J Rheumatol 1992; 19: 8848.
  • 8
    Siegert CE, Daha MR, Swaak AJ, Van Der Voort EA, Breedveld FC. The relationship between serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1993; 67: 2049.
  • 9
    Antes U, Heinz HP, Loos M. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus. Arthritis Rheum 1988; 31: 45764.
  • 10
    Fremeaux-Bacchi V, Weiss L, Demouchy C, Blouin J, Kazatchkine MD. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus. Lupus 1996; 5: 21620.
  • 11
    Siegert C, Daha M, Van Westedt ML, Van Der Voort EA, Breedveld F. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol 1991; 18: 2304.
  • 12
    Mannik M, Wener MH. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum 1997; 40: 150411.
  • 13
    Coremans IE, Spronk PE, Bootsma H et al. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 1995; 26: 595601.
  • 14
    Moroni G, Trendelenburg M, Del Papa N et al. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 2001; 37: 4908.
  • 15
    Trendelenburg M, Marfurt J, Gerber I, Tyndall A, Schifferli JA. Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients. Arthritis Rheum 1999; 42: 1878.
  • 16
    Uwatoko S, Gauthier VJ, Mannik M. Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits. Clin Immunol Immunopathol 1991; 61: 26873.
  • 17
    Coremans IE, Bruijn JA, De Heer E, Van Der Voort EAM, Breedveld FC, Daha M. Stabilization of glomerular deposits of C1q by antibodies against C1q in mice. J Clin Lab Immunol 1995; 44: 4761.
  • 18
    Wing MG, Seilly DJ, Bridgman DJ, Harrison RA. Rapid isolation and biochemical characterization of rat C1 and C1q. Mol Immunol 1993; 30: 43340.
  • 19
    Botto M, Dell’Agnola C, Bygrave AE et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998; 19: 569.
  • 20
    Kohro-Kawata J, Wener MH, Mannik M. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus. J Rheumatol 2002; 29: 849.
  • 21
    Siegert CE, Daha MR, Van Der Voort EA, Breedveld FC. IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis. Arthritis Rheum 1990; 33: 164654.
  • 22
    Walport MJ. Complement and systemic lupus erythematosus. Arthritis Res 2002; 4 (Suppl. 3):S279S293.
  • 23
    Bengtsson A, Nezlin R, Shoenfeld Y, Sturfelt G. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q. J Autoimmun 1999; 13: 1119.
  • 24
    Nangaku M. Complement regulatory proteins in glomerular diseases. Kidney Int 1998; 54: 141928.
  • 25
    Lin F, Emancipator SN, Salant DJ, Medof ME. Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis. Lab Invest 2002; 82: 5639.
  • 26
    Sogabe H, Nangaku M, Ishibashi Y et al. Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis. J Immunol 2001; 167: 27917.
  • 27
    Kootstra JC, Veninga A, Baelde JJ, Van Eendenburg J, De Heer E, Bruijn JA. Characterization of reactivity of monoclonal autoantibodies with renal antigens in experimental lupus nephritis. J Clin Lab Immunol 1996; 48: 20118.